Drug General Information
Drug ID
D0U0KY
Former ID
DNC003526
Drug Name
8-(2,6-Dichloro-phenyl)-9H-purine-2,6-diamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534468]
Formula
C11H8Cl2N6
Canonical SMILES
C1=CC(=C(C(=C1)Cl)C2=NC3=C(N2)C(=NC(=N3)N)N)Cl
InChI
1S/C11H8Cl2N6/c12-4-2-1-3-5(13)6(4)9-16-7-8(14)17-11(15)19-10(7)18-9/h1-3H,(H5,14,15,16,17,18,19)
InChIKey
ZBIYAIOEBKNMQY-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Dihydrofolate reductase Target Info Inhibitor [534468]
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
References
Ref 534468J Med Chem. 1997 Sep 12;40(19):3032-9.Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii.
Ref 534468J Med Chem. 1997 Sep 12;40(19):3032-9.Conformationally restricted analogues of trimethoprim: 2,6-diamino-8-substituted purines as potential dihydrofolate reductase inhibitors from Pneumocystis carinii and Toxoplasma gondii.